Compare FOA & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FOA | EMBC |
|---|---|---|
| Founded | 2013 | 1924 |
| Country | United States | United States |
| Employees | 784 | N/A |
| Industry | Finance Companies | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 177.1M | 199.9M |
| IPO Year | N/A | 2021 |
| Metric | FOA | EMBC |
|---|---|---|
| Price | $22.40 | $3.22 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $26.00 | $18.50 |
| AVG Volume (30 Days) | 66.8K | ★ 2.4M |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 6.88% |
| EPS Growth | N/A | ★ 20.90 |
| EPS | N/A | ★ 0.67 |
| Revenue | N/A | N/A |
| Revenue This Year | $0.58 | $1.17 |
| Revenue Next Year | $6.91 | N/A |
| P/E Ratio | ★ N/A | $4.85 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $15.77 | $2.77 |
| 52 Week High | $29.79 | $15.55 |
| Indicator | FOA | EMBC |
|---|---|---|
| Relative Strength Index (RSI) | N/A | N/A |
| Support Level | N/A | N/A |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.00 | 0.00 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 0.00 | 0.00 |
Finance of America Companies Inc provides home equity-based financing solutions for modern retirement and offers capital markets and portfolio management capabilities to optimize loan distribution to investors. The Company operates through two segments: Retirement Solutions and Portfolio Management. The Retirement Solutions segment handles loan origination, including HECM and non-agency reverse mortgage loans, generating revenue from origination fees and initial gains, with loans transferred to the Portfolio Management segment. The Portfolio Management segment, which generates the majority of revenue, provides securitization, loan sales, risk management, and asset management services, and earns revenue from net interest income, fair value changes, and servicing-related income.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.